NDC 62795-1019

BHI Migraine

Acetic Acid, Araneus Diadematus, Asafetida, Bryonia Alba Whole, Tribasic Calcium Phosphate, Activated Charcoal, Cinchona Officinalis Bark, Marsdenia Condurango Bark, Tubocurarine Chloride, Kalmia Latifolia Leaf, Lycopodium Clavatum Spore, Sodium Sulfate, Phosphoric Acid, Pulsatilla Vulgaris, Claviceps Purpurea Sclerotium, And Silicon Dioxide

BHI Migraine is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Medinatura Inc. The primary component is Acetic Acid; Araneus Diadematus; Asafetida; Bryonia Alba Whole; Tribasic Calcium Phosphate; Activated Charcoal; Cinchona Officinalis Bark; Marsdenia Condurango Bark; Tubocurarine Chloride; Kalmia Latifolia Leaf; Lycopodium Clavatum Spore; Sodium Sulfate; Phosphoric Acid; Pulsatilla Vulgaris; Claviceps Purpurea Sclerotium; Silicon Dioxide; Strychnine Nitrate.

Product ID62795-1019_6185581f-eafe-4118-abc7-73636119c2bf
NDC62795-1019
Product TypeHuman Otc Drug
Proprietary NameBHI Migraine
Generic NameAcetic Acid, Araneus Diadematus, Asafetida, Bryonia Alba Whole, Tribasic Calcium Phosphate, Activated Charcoal, Cinchona Officinalis Bark, Marsdenia Condurango Bark, Tubocurarine Chloride, Kalmia Latifolia Leaf, Lycopodium Clavatum Spore, Sodium Sulfate, Phosphoric Acid, Pulsatilla Vulgaris, Claviceps Purpurea Sclerotium, And Silicon Dioxide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-01-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameMediNatura Inc
Substance NameACETIC ACID; ARANEUS DIADEMATUS; ASAFETIDA; BRYONIA ALBA WHOLE; TRIBASIC CALCIUM PHOSPHATE; ACTIVATED CHARCOAL; CINCHONA OFFICINALIS BARK; MARSDENIA CONDURANGO BARK; TUBOCURARINE CHLORIDE; KALMIA LATIFOLIA LEAF; LYCOPODIUM CLAVATUM SPORE; SODIUM SULFATE; PHOSPHORIC ACID; PULSATILLA VULGARIS; CLAVICEPS PURPUREA SCLEROTIUM; SILICON DIOXIDE; STRYCHNINE NITRATE
Active Ingredient Strength6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 62795-1019-3

1 BOTTLE in 1 CARTON (62795-1019-3) > 100 TABLET in 1 BOTTLE
Marketing Start Date2015-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62795-1019-2 [62795101902]

BHI Migraine TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2015-01-01

Drug Details

Active Ingredients

IngredientStrength
ACETIC ACID6 [hp_X]/1

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.